Market research
ANCR.LSE Animalcare Group plc
LSE GBP Healthcare
Latest close
As of 12 Aug 2026
Test a moving-average rule with historical data.
Market facts
- Market cap
- 231M
- P/E ratio
- 47.86
- Analyst target
- 336
- Dividend yield
- 0.7%
- Beta
- 0.67
Profile
Instrument facts
- Exchange
- LSE
- Currency
- GBP
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- ISIN
- GB0032350695
- Market cap
- 231M
- P/E ratio
- 47.86
- Analyst target
- 336
- Dividend yield
- 0.7%
- Beta
- 0.67
About
About Animalcare Group plc
Animalcare Group plc develops, sells, and distributes licensed veterinary pharmaceuticals for the companion animal, production animal, and equine veterinary markets in Europe, the Asia-Pacific, and internationally. It operates through Animalcare Europe and Randlab segments. The company offers Orozyme, an enzymatic toothpaste for dental care in cats and dogs; Danilon, an oral treatment for pain in horses; Dinalgen, an injectable treatment for pain in cattle, pigs, and horses; Aqupharm, a dehydration treatment for cats, dogs, cattle, goats, horses, pigs, rabbits, and sheep; Ulcershield, a treatment and prevention of gastric ulcers in horses; Daxocox, a treatment of osteoarthritis pain and inflammation in dogs; Plaqtiv+, a biofilm-based dental care for cats and dogs; Thiamacare, a treatment for hyperthyroidism in cats; Hemo, an injectable nutritional solution for horses; and Cosequin, a complementary feed for dogs and cats to strengthen and protect joints. It also provides nutritional supplements for the equine market; and professional support services to equine veterinarians. The company exports its products to approximately 45 countries. It has a collaboration with 272Bio to develop and commercialize a novel biological treatment for equine sweet itch. Animalcare Group plc is based in York, the United Kingdom.
Research context
Animalcare Group plc appears in PyInvesting’s London Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- GBP
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
Community
Investor discussion
1 comment
Sign in to join the ANCR.LSE discussion.
5 years, 6 months ago
Animalcare Group plc is currently in a long term uptrend where the price is trading 27.2% above its 200 day moving average.
From a valuation standpoint, the stock is 99.6% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 2.0.
Finally, its free cash flow fell by 2.8% to $4M since the same quarter in the previous year.
Based on the above factors, Animalcare Group plc gets an overall score of 2/5.